• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.自身免疫性疾病发病机制中的Toll样受体
Adv Pharm Bull. 2015 Dec;5(Suppl 1):605-14. doi: 10.15171/apb.2015.082. Epub 2015 Dec 31.
2
Toll like receptors and autoimmunity: a critical appraisal.Toll样受体与自身免疫:批判性评估
J Autoimmun. 2007 Dec;29(4):310-8. doi: 10.1016/j.jaut.2007.09.001. Epub 2007 Oct 24.
3
Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals.Toll 样受体:在哺乳动物中的意义、配体、信号通路和功能。
Int Rev Immunol. 2018 Jan 2;37(1):20-36. doi: 10.1080/08830185.2017.1380200. Epub 2017 Oct 13.
4
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.结直肠癌中的Toll样受体信号传导:从致癌作用到癌症治疗
World J Gastroenterol. 2014 Dec 21;20(47):17699-708. doi: 10.3748/wjg.v20.i47.17699.
5
Toll-like Receptors in the Vascular System: Sensing the Dangers Within.血管系统中的Toll样受体:感知体内危险
Pharmacol Rev. 2016 Jan;68(1):142-67. doi: 10.1124/pr.114.010090.
6
[Responses with participation of toll-like receptors in protective immunity and in pathologic states].[Toll样受体参与保护性免疫和病理状态的反应]
Ukr Biokhim Zh (1999). 2008 May-Jun;80(3):5-20.
7
Toll-like receptors on the fork roads between innate and adaptive immunity. Toll 样受体在固有免疫和适应性免疫的分岔路口。
Hum Immunol. 2011 Dec;72(12):1188-93. doi: 10.1016/j.humimm.2011.08.015. Epub 2011 Aug 28.
8
Toll-like receptors in inflammation of the central nervous system. Toll 样受体在中枢神经系统炎症中的作用。
Int Immunopharmacol. 2011 Oct;11(10):1407-14. doi: 10.1016/j.intimp.2011.04.025. Epub 2011 May 18.
9
RAGE and TLRs: relatives, friends or neighbours?RAGE 和 TLRs:亲戚、朋友还是邻居?
Mol Immunol. 2013 Dec;56(4):739-44. doi: 10.1016/j.molimm.2013.07.008. Epub 2013 Aug 14.
10
The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.Toll 样受体信号通路在无菌性炎症性疾病中的重要作用。
Int Immunopharmacol. 2011 Oct;11(10):1422-32. doi: 10.1016/j.intimp.2011.04.026. Epub 2011 May 18.

引用本文的文献

1
Discovery of ETI41 and ETI60: novel selective endosomal Toll-like receptor inhibitors for the treatment of autoimmune diseases.ETI41和ETI60的发现:用于治疗自身免疫性疾病的新型选择性内体Toll样受体抑制剂。
Exp Mol Med. 2025 Sep 1. doi: 10.1038/s12276-025-01526-w.
2
Virus-Triggered Autoimmunity Was Associated With Hirschsprung's Disease Through Activation of Innate Immunity.病毒触发的自身免疫与先天性免疫的激活有关,与先天性巨结肠病有关。
J Immunol Res. 2024 Oct 26;2024:4838514. doi: 10.1155/2024/4838514. eCollection 2024.
3
Evaluation of the Anti-Inflammatory/Immunomodulatory Effect of L. Extract in Collagen-Induced Arthritis in Rats.L.提取物对大鼠胶原诱导性关节炎抗炎/免疫调节作用的评价
Biology (Basel). 2024 Oct 12;13(10):818. doi: 10.3390/biology13100818.
4
TLR4 induced TRPM2 mediated neuropathic pain.Toll样受体4(TLR4)诱导瞬时受体电位阳离子通道M2型(TRPM2)介导神经性疼痛。
Front Pharmacol. 2024 Sep 12;15:1472771. doi: 10.3389/fphar.2024.1472771. eCollection 2024.
5
Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications.解析 Toll 样受体的复杂性:从分子机制到临床应用。
Int J Mol Sci. 2024 May 5;25(9):5037. doi: 10.3390/ijms25095037.
6
miR-154-5p Is a Novel Endogenous Ligand for TLR7 Inducing Microglial Activation and Neuronal Injury.miR-154-5p是一种新型TLR7内源性配体,可诱导小胶质细胞活化和神经元损伤。
Cells. 2024 Feb 26;13(5):407. doi: 10.3390/cells13050407.
7
New-onset Seropositive Rheumatoid Arthritis Post-mRNA COVID-19 Vaccine: A Case Report.mRNA新冠疫苗接种后新发血清阳性类风湿关节炎:一例报告
Oman Med J. 2024 Jan 31;39(4):e597. doi: 10.5001/omj.2024.06. eCollection 2024 Jan.
8
RNA Binding Proteins that Mediate LPS-induced Alternative Splicing of the MyD88 Innate Immune Regulator.RNA 结合蛋白介导 LPS 诱导的 MyD88 先天免疫调节剂的可变剪接。
J Mol Biol. 2024 Apr 15;436(8):168497. doi: 10.1016/j.jmb.2024.168497. Epub 2024 Feb 17.
9
deficiency exacerbates lupus-like disease in the MRL/ mouse model.缺乏会加剧 MRL/ 小鼠模型中的狼疮样疾病。
Front Immunol. 2024 Jan 30;15:1359534. doi: 10.3389/fimmu.2024.1359534. eCollection 2024.
10
A systematic review of dysregulated microRNAs in Hashimoto's thyroiditis.桥本甲状腺炎中失调 microRNAs 的系统评价
Endocrine. 2024 Jun;84(3):800-811. doi: 10.1007/s12020-023-03673-4. Epub 2024 Jan 12.

本文引用的文献

1
Role of toll-like receptors in multiple sclerosis.Toll样受体在多发性硬化症中的作用。
Am J Clin Exp Immunol. 2013 Feb 27;2(1):75-93. Print 2013.
2
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.负调控 Toll 样受体信号转导的方法。
Exp Mol Med. 2013 Feb 22;45(2):e11. doi: 10.1038/emm.2013.28.
3
TLR7 and TLR9 in SLE: when sensing self goes wrong.TLR7 和 TLR9 在系统性红斑狼疮中的作用:自身识别出现差错时。
Immunol Res. 2012 Sep;53(1-3):58-77. doi: 10.1007/s12026-012-8270-1.
4
TLR-dependent T cell activation in autoimmunity.TLR 依赖性 T 细胞在自身免疫中的活化。
Nat Rev Immunol. 2011 Nov 18;11(12):807-22. doi: 10.1038/nri3095.
5
Nucleic acid-binding polymers as anti-inflammatory agents.核酸结合聚合物作为抗炎剂。
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14055-60. doi: 10.1073/pnas.1105777108. Epub 2011 Aug 15.
6
B cell toll-like receptors with respect to the pathogenesis of Sjögren's syndrome.与干燥综合征发病机制相关的B细胞 toll 样受体
Acta Medica (Hradec Kralove). 2011;54(2):51-7. doi: 10.14712/18059694.2016.18.
7
Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Toll 样受体驱动的 B 细胞激活在系统性自身免疫中的诱导作用。
Semin Immunol. 2011 Apr;23(2):106-12. doi: 10.1016/j.smim.2011.01.016.
8
Toll-like receptor signaling pathways--therapeutic opportunities. Toll 样受体信号通路——治疗机会。
Mediators Inflamm. 2010;2010:781235. doi: 10.1155/2010/781235. Epub 2010 Oct 17.
9
Targeting Toll-like receptors for treatment of SLE.针对 Toll 样受体治疗系统性红斑狼疮。
Mediators Inflamm. 2010;2010. doi: 10.1155/2010/498980. Epub 2010 Sep 19.
10
Modulation of B cell responses by Toll-like receptors.Toll 样受体对 B 细胞应答的调节。
Cell Tissue Res. 2011 Jan;343(1):131-40. doi: 10.1007/s00441-010-1031-3. Epub 2010 Sep 8.

自身免疫性疾病发病机制中的Toll样受体

Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.

作者信息

Mohammad Hosseini Akbar, Majidi Jafar, Baradaran Behzad, Yousefi Mehdi

机构信息

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2015 Dec;5(Suppl 1):605-14. doi: 10.15171/apb.2015.082. Epub 2015 Dec 31.

DOI:10.15171/apb.2015.082
PMID:26793605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4708030/
Abstract

Human Toll-like receptors (TLRs) are a family of transmembrane receptors, which play a key role in both innate and adaptive immune responses. Beside of recognizing specific molecular patterns that associated with different types of pathogens, TLRs may also detect a number of self-proteins and endogenous nucleic acids. Activating TLRs lead to the heightened expression of various inflammatory genes, which have a protective role against infection. Data rising predominantly from human patients and animal models of autoimmune disease indicate that, inappropriate triggering of TLR pathways by exogenous or endogenous ligands may cause the initiation and/or perpetuation of autoimmune reactions and tissue damage. Given their important role in infectious and non-infectious disease process, TLRs and its signaling pathways emerge as appealing targets for therapeutics. In this review, we demonstrate how TLRs pathways could be involved in autoimmune disorders and their therapeutic application.

摘要

人类 Toll 样受体(TLR)是一类跨膜受体家族,在先天性和适应性免疫反应中均发挥关键作用。除了识别与不同类型病原体相关的特定分子模式外,TLR 还可能检测多种自身蛋白和内源性核酸。激活 TLR 会导致各种炎症基因的表达增强,这些基因对感染具有保护作用。主要来自人类患者和自身免疫性疾病动物模型的数据表明,外源性或内源性配体对 TLR 通路的不适当触发可能会导致自身免疫反应和组织损伤的启动和/或持续。鉴于 TLR 在感染性和非感染性疾病过程中的重要作用,TLR 及其信号通路成为有吸引力的治疗靶点。在本综述中,我们阐述了 TLR 通路如何参与自身免疫性疾病及其治疗应用。